{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:40:16Z","timestamp":1773294016988,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study investigated whether long-term treatment with antiepileptic drugs (AEDs) had negative effects on statural growth and serum calcium levels in children with epilepsy in Taiwan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Children with epilepsy treated with one prescription of AEDs (monotherapy) for at least 1\u00a0year were selected. The AEDs included valproic acid (VPA; Deparkin) in 27 children (11 boys and 16 girls) aged 4-18\u00a0years, oxcarbazepine (Trileptal) in 30 children (15 boys and 15 girls) aged 5-18\u00a0years, topiramate (Topamax) in 19 children (10 boys and 9 girls) aged 6-18\u00a0years, and lamotrigine (Lamicta) in eight children (5 boys and 3 girls) aged 5-13\u00a0years. Patients with a history of febrile convulsions were selected as the controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One year of VPA treatment significantly impaired the statural growth of pediatric patients with epilepsy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005) compared with the control group. The underlying mechanism may have been due to the direct effect of VPA on the proliferation of growth plate chondrocytes rather than alterations of serum calcium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These results raise serious concerns about the growth of pediatric epilepsy patients who use AEDs, and potentially the need to closely monitor growth in children with epilepsy and adolescents under AED treatment, especially VPA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2431-13-211","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T14:01:56Z","timestamp":1387461716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The impact of the use of antiepileptic drugs on the growth of children"],"prefix":"10.1186","volume":"13","author":[{"given":"Herng-Sheng","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald M","family":"Salter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyi-Jou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hueng-Chuen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,19]]},"reference":[{"key":"937_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1586\/erd.10.17","volume":"7","author":"U Ripamonti","year":"2010","unstructured":"Ripamonti U, Roden L: Biomimetics for the induction of bone formation. Expert Rev Med Devices. 2010, 7: 469-479. 10.1586\/erd.10.17.","journal-title":"Expert Rev Med Devices"},{"key":"937_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1210\/er.2002-0033","volume":"24","author":"BC van der Eerden","year":"2003","unstructured":"van der Eerden BC, Karperien M, Wit JM: Systemic and local regulation of the growth plate. Endocr Rev. 2003, 24: 782-801. 10.1210\/er.2002-0033.","journal-title":"Endocr Rev"},{"key":"937_CR3","first-page":"194","volume":"5","author":"F Rauch","year":"2005","unstructured":"Rauch F: Bone growth in length and width: the Yin and Yang of bone stability. J Musculoskelet Neuronal Interact. 2005, 5: 194-201.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"937_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/154411130401500302","volume":"15","author":"C Qin","year":"2004","unstructured":"Qin C, Baba O, Butler WT: Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med. 2004, 15: 126-136. 10.1177\/154411130401500302.","journal-title":"Crit Rev Oral Biol Med"},{"key":"937_CR5","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1210\/en.2005-0437","volume":"146","author":"L Rodriguez","year":"2005","unstructured":"Rodriguez L, Cheng Z, Chen TH, Tu C, Chang W: Extracellular calcium and parathyroid hormone-related peptide signaling modulate the pace of growth plate chondrocyte differentiation. Endocrinology. 2005, 146: 4597-4608. 10.1210\/en.2005-0437.","journal-title":"Endocrinology"},{"key":"937_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","volume":"46","author":"RS Fisher","year":"2005","unstructured":"Fisher RS, van Emde BW, Blume W, Elger C, Genton P, Lee P, Engel J: Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005, 46: 470-472. 10.1111\/j.0013-9580.2005.66104.x.","journal-title":"Epilepsia"},{"key":"937_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eplepsyres.2006.07.007","volume":"72","author":"CC Chen","year":"2006","unstructured":"Chen CC, Chen TF, Hwang YC, Wen YR, Chiu YH, Wu CY, Chen RC, Chen TH, Liou HH: Population-based survey on prevalence of adult patients with epilepsy in Taiwan (Keelung community-based integrated screening no. 12). Epilepsy Res. 2006, 72: 67-74. 10.1016\/j.eplepsyres.2006.07.007.","journal-title":"Epilepsy Res"},{"issue":"Suppl 2","key":"937_CR8","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1111\/j.1528-1157.2000.tb01523.x","volume":"41","author":"RS Greenwood","year":"2000","unstructured":"Greenwood RS: Adverse effects of antiepileptic drugs. Epilepsia. 2000, 41 (Suppl 2): S42-S52.","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"937_CR9","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.3949\/ccjm.71.Suppl_2.S42","volume":"71","author":"AM Pack","year":"2004","unstructured":"Pack AM, Gidal B, Vazquez B: Bone disease associated with antiepileptic drugs. Cleve Clin J Med. 2004, 71 (Suppl 2): S42-S48.","journal-title":"Cleve Clin J Med"},{"key":"937_CR10","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1212\/WNL.63.10_suppl_4.S24","volume":"63","author":"RD Sheth","year":"2004","unstructured":"Sheth RD: Metabolic concerns associated with antiepileptic medications. Neurology. 2004, 63: S24-S29.","journal-title":"Neurology"},{"key":"937_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/archneur.58.9.1369","volume":"58","author":"C Valmadrid","year":"2001","unstructured":"Valmadrid C, Voorhees C, Litt B, Schneyer CR: Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol. 2001, 58: 1369-1374. 10.1001\/archneur.58.9.1369.","journal-title":"Arch Neurol"},{"key":"937_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/adc.56.6.446","volume":"56","author":"Y Morijiri","year":"1981","unstructured":"Morijiri Y, Sato T: Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. Arch Dis Child. 1981, 56: 446-449. 10.1136\/adc.56.6.446.","journal-title":"Arch Dis Child"},{"key":"937_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","volume":"112","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P: Epilepsy, osteoporosis and fracture risk - a meta-analysis. Acta Neurol Scand. 2005, 112: 277-286. 10.1111\/j.1600-0404.2005.00474.x.","journal-title":"Acta Neurol Scand"},{"key":"937_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.bdj.4804977","volume":"154","author":"PB Robinson","year":"1983","unstructured":"Robinson PB, Harris M, Harvey W: Abnormal skeletal and dental growth in epileptic children. Br Dent J. 1983, 154: 9-13. 10.1038\/sj.bdj.4804977.","journal-title":"Br Dent J"},{"key":"937_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1046\/j.1528-1157.2001.416800.x","volume":"42","author":"CY Guo","year":"2001","unstructured":"Guo CY, Ronen GM, Atkinson SA: Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 2001, 42: 1141-1147.","journal-title":"Epilepsia"},{"key":"937_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.seizure.2007.11.020","volume":"17","author":"A Pack","year":"2008","unstructured":"Pack A: Bone health in people with epilepsy: is it impaired and what are the risk factors?. Seizure. 2008, 17: 181-186. 10.1016\/j.seizure.2007.11.020.","journal-title":"Seizure"},{"key":"937_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.spen.2007.08.006","volume":"14","author":"EA Samaniego","year":"2007","unstructured":"Samaniego EA, Sheth RD: Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol. 2007, 14: 196-200. 10.1016\/j.spen.2007.08.006.","journal-title":"Semin Pediatr Neurol"},{"key":"937_CR18","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1212\/01.wnl.0000210503.89488.88","volume":"66","author":"PC Souverein","year":"2006","unstructured":"Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC: Use of antiepileptic drugs and risk of fractures: case\u2013control study among patients with epilepsy. Neurology. 2006, 66: 1318-1324. 10.1212\/01.wnl.0000210503.89488.88.","journal-title":"Neurology"},{"key":"937_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","volume":"51","author":"AT Berg","year":"2010","unstructured":"Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE: Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005\u20132009. Epilepsia. 2010, 51: 676-685. 10.1111\/j.1528-1167.2010.02522.x.","journal-title":"Epilepsia"},{"key":"937_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.neuropharm.2010.01.007","volume":"58","author":"C Luna-Tortos","year":"2010","unstructured":"Luna-Tortos C, Fedrowitz M, Loscher W: Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 2010, 58: 1019-1032. 10.1016\/j.neuropharm.2010.01.007.","journal-title":"Neuropharmacology"},{"key":"937_CR21","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/ar1948","volume":"8","author":"C Brochhausen","year":"2006","unstructured":"Brochhausen C, Neuland P, Kirkpatrick CJ, Nusing RM, Klaus G: Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ\u2013prostaglandin E2 dependent proliferation of growth plate chondrocytes. Arthritis Res Ther. 2006, 8: R78-10.1186\/ar1948.","journal-title":"Arthritis Res Ther"},{"key":"937_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.joca.2008.05.010","volume":"17","author":"HS Lee","year":"2009","unstructured":"Lee HS, Lee CH, Tsai HC, Salter DM: Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1beta. Osteoarthritis Cartilage. 2009, 17: 91-99. 10.1016\/j.joca.2008.05.010.","journal-title":"Osteoarthritis Cartilage"},{"key":"937_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0022-3476(95)70304-7","volume":"127","author":"RD Sheth","year":"1995","unstructured":"Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB: Effect of carbamazepine and valproate on bone mineral density. J Pediatr. 1995, 127: 256-262. 10.1016\/S0022-3476(95)70304-7.","journal-title":"J Pediatr"},{"key":"937_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/000992289903800205","volume":"38","author":"G Kafali","year":"1999","unstructured":"Kafali G, Erselcan T, Tanzer F: Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12\u00a0years. Clin Pediatr (Phila). 1999, 38: 93-98. 10.1177\/000992289903800205.","journal-title":"Clin Pediatr (Phila)"},{"key":"937_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1535-7597.2003.03306.x","volume":"3","author":"AM Pack","year":"2003","unstructured":"Pack AM: The association between antiepileptic drugs and bone disease. Epilepsy Curr. 2003, 3: 91-95. 10.1046\/j.1535-7597.2003.03306.x.","journal-title":"Epilepsy Curr"},{"key":"937_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.yebeh.2004.02.005","volume":"5","author":"II Ali","year":"2004","unstructured":"Ali II, Schuh L, Barkley GL, Gates JR: Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav. 2004, 5: 296-300. 10.1016\/j.yebeh.2004.02.005.","journal-title":"Epilepsy Behav"},{"key":"937_CR27","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archneur.59.5.781","volume":"59","author":"DL Andress","year":"2002","unstructured":"Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W: Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol. 2002, 59: 781-786. 10.1001\/archneur.59.5.781.","journal-title":"Arch Neurol"},{"key":"937_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jbmr.5650090507","volume":"9","author":"MJ Valimaki","year":"1994","unstructured":"Valimaki MJ, Tiihonen M, Laitinen K, Tahtela R, Karkkainen M, Lamberg-Allardt C, Makela P, Tunninen R: Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res. 1994, 9: 631-637.","journal-title":"J Bone Miner Res"},{"key":"937_CR29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/jcem-58-6-1003","volume":"58","author":"RS Weinstein","year":"1984","unstructured":"Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB: Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab. 1984, 58: 1003-1009. 10.1210\/jcem-58-6-1003.","journal-title":"J Clin Endocrinol Metab"},{"key":"937_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","volume":"52","author":"X Wen","year":"2001","unstructured":"Wen X, Wang JS, Kivisto KT, Neuvonen PJ, Backman JT: In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9). Br J Clin Pharmacol. 2001, 52: 547-553. 10.1046\/j.0306-5251.2001.01474.x.","journal-title":"Br J Clin Pharmacol"},{"key":"937_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/archneurol.2010.341","volume":"68","author":"N Jette","year":"2011","unstructured":"Jette N, Lix LM, Metge CJ, Prior HJ, McChesney J, Leslie WD: Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol. 2011, 68: 107-112.","journal-title":"Arch Neurol"},{"key":"937_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2009.10.011","volume":"112","author":"A Verrotti","year":"2010","unstructured":"Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F: Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010, 112: 1-10. 10.1016\/j.clineuro.2009.10.011.","journal-title":"Clin Neurol Neurosurg"},{"key":"937_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1212\/WNL.57.3.445","volume":"57","author":"Y Sato","year":"2001","unstructured":"Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K: Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001, 57: 445-449. 10.1212\/WNL.57.3.445.","journal-title":"Neurology"},{"key":"937_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ana.20378","volume":"57","author":"AM Pack","year":"2005","unstructured":"Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, Randall A, Seale C, Shane E: Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol. 2005, 57: 252-257. 10.1002\/ana.20378.","journal-title":"Ann Neurol"},{"key":"937_CR35","first-page":"933","volume":"13","author":"AE Erbayat","year":"2000","unstructured":"Erbayat AE, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A: Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab. 2000, 13: 933-939.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"937_CR36","first-page":"569","volume":"59","author":"H Gough","year":"1986","unstructured":"Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N: A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med. 1986, 59: 569-577.","journal-title":"Q J Med"},{"key":"937_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-0404.1999.tb00675.x","volume":"99","author":"P Vestergaard","year":"1999","unstructured":"Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L: Fracture risk is increased in epilepsy. Acta Neurol Scand. 1999, 99: 269-275. 10.1111\/j.1600-0404.1999.tb00675.x.","journal-title":"Acta Neurol Scand"},{"key":"937_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","volume":"47","author":"S Mintzer","year":"2006","unstructured":"Mintzer S, Boppana P, Toguri J, DeSantis A: Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006, 47: 510-515. 10.1111\/j.1528-1167.2006.00460.x.","journal-title":"Epilepsia"},{"key":"937_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-2125.2009.03521.x","volume":"68","author":"N Mirza","year":"2009","unstructured":"Mirza N, Marson AG, Pirmohamed M: Effect of topiramate on acid\u2013base balance: extent, mechanism and effects. Br J Clin Pharmacol. 2009, 68: 655-661. 10.1111\/j.1365-2125.2009.03521.x.","journal-title":"Br J Clin Pharmacol"},{"key":"937_CR40","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/j.1528-1167.2011.03131.x","volume":"52","author":"K Heo","year":"2011","unstructured":"Heo K, Rhee Y, Lee HW, Lee SA, Shin DJ, Kim WJ, Song HK, Song K, Lee BI: The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Epilepsia. 2011, 52: 1884-1889. 10.1111\/j.1528-1167.2011.03131.x.","journal-title":"Epilepsia"},{"key":"937_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.drudis.2009.01.004","volume":"14","author":"S Khanna","year":"2009","unstructured":"Khanna S, Pillai KK, Vohora D: Insights into liaison between antiepileptic drugs and bone. Drug Discov Today. 2009, 14: 428-435. 10.1016\/j.drudis.2009.01.004.","journal-title":"Drug Discov Today"},{"key":"937_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","volume":"10","author":"SH Kim","year":"2007","unstructured":"Kim SH, Lee JW, Choi KG, Chung HW, Lee HW: A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav. 2007, 10: 291-295. 10.1016\/j.yebeh.2006.11.007.","journal-title":"Epilepsy Behav"},{"key":"937_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pediatrneurol.2007.05.018","volume":"37","author":"RD Sheth","year":"2007","unstructured":"Sheth RD, Hermann BP: Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol. 2007, 37: 250-254. 10.1016\/j.pediatrneurol.2007.05.018.","journal-title":"Pediatr Neurol"},{"key":"937_CR44","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1128\/MCB.22.20.7302-7312.2002","volume":"22","author":"CL Zhang","year":"2002","unstructured":"Zhang CL, McKinsey TA, Olson EN: Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol Cell Biol. 2002, 22: 7302-7312. 10.1128\/MCB.22.20.7302-7312.2002.","journal-title":"Mol Cell Biol"},{"key":"937_CR45","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/CAD.0b013e32834a2c70","volume":"22","author":"S Vallo","year":"2011","unstructured":"Vallo S, Xi W, Hudak L, Juengel E, Tsaur I, Wiesner C, Haferkamp A, Blaheta RA: HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro. Anticancer Drugs. 2011, 22: 1002-1009.","journal-title":"Anticancer Drugs"},{"key":"937_CR46","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","volume":"89","author":"M Ren","year":"2004","unstructured":"Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM: Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem. 2004, 89: 1358-1367. 10.1111\/j.1471-4159.2004.02406.x.","journal-title":"J Neurochem"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-13-211\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:27:08Z","timestamp":1630549628000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-13-211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["937"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-13-211","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"8 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"211"}}